AU Patent

AU2013261127A1 — Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Assigned to Novartis AG · Expires 2014-11-20 · 11y expired

What this patent protects

The present invention relates to compounds of formula (I): in which Y, Y

USPTO Abstract

The present invention relates to compounds of formula (I): in which Y, Y

Drugs covered by this patent

Patent Metadata

Patent number
AU2013261127A1
Jurisdiction
AU
Classification
—
Expires
2014-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.